DUO-HYBRID Stent
Commercial- Indications
- Deep venous disease
Company intelligence / Profile preview
Vesper Medical
Wayne, Pennsylvania, United Statesvespermedical.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Vesper Medical developed the DUO Venous Stent System, designed to address multiple anatomical challenges in the deep venous system for patients with chronic venous insufficiency. The company achieved CE Mark in Europe and initiated the pivotal VIVID clinical trial in the US for FDA approval before being acquired by Royal Philips in 2022.
- Therapeutic areas
- Cardiovascular
- Modalities
- DeviceVenous stent system (medical device)
- Industry
- Implantable Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Vesper Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vesper Medical.